Interleukin 1 Induces Leukocyte Infiltration and Cartilage Proteoglycan Degradation in the Synovial Joint

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1986 Nov 1

PMID 3490671

Citations 154

Authors

E R Pettipher

G A Higgs

B Henderson

Affiliations

Soon will be listed here.

Abstract

Interleukin 1 (IL-1) is a polypeptide released by activated macrophages and is thought to be a key mediator of host responses to infection and inflammation. The availability of highly purified and recombinant material has now permitted the evaluation of IL-1 as a mediator of chronic inflammatory processes in vivo. We have demonstrated that intraarticular injection of IL-1 into rabbit knee joints induces the accumulation of polymorphonuclear and mononuclear leukocytes in the joint space and the loss of proteoglycan from the articular cartilage. The effects on cartilage could not be explained solely by the presence of leukocytes, since injections of endotoxin also stimulated leukocyte accumulation in the joint but had no effect on proteoglycan loss. Responses to IL-1 were not associated with increased production of the icosanoids prostaglandin E2 or leukotriene B4 and were not reduced by an inhibitor of their synthesis. The pattern of leukocyte infiltration and cartilage breakdown 24 hr after IL-1 injection was similar to that seen in animals with antigen-induced arthritis of 1 week's duration. These observations support the hypothesis that IL-1 acts directly to mediate the erosive processes of chronic arthritis.

Citing Articles

Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS).

Cai G, Jones G, Cicuttini F, Wluka A, Wang Y, Hill C Trials. 2022; 23(1):768.

PMID: 36089595 PMC: 9464426. DOI: 10.1186/s13063-022-06715-w.

Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research.

Kim M, Choe Y, Lee S Immune Netw. 2022; 22(1):e8.

PMID: 35291656 PMC: 8901706. DOI: 10.4110/in.2022.22.e8.

Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review).

Liu S, Deng Z, Chen K, Jian S, Zhou F, Yang Y Mol Med Rep. 2022; 25(3).

PMID: 35088882 PMC: 8809050. DOI: 10.3892/mmr.2022.12615.

FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer.

Larsson P, Karlsson R, Sarwar M, Miftakhova R, Wang T, Syed Khaja A Mol Oncol. 2021; 16(13):2496-2517.

PMID: 34932854 PMC: 9251882. DOI: 10.1002/1878-0261.13166.

There is an Association of Synovial Interleukin-6 Levels With Chondral Damage in Anterior Cruciate Ligament-Deficient Knees.

Gupta R, Kapoor A, Khatri S, Sandal D, Masih G HSS J. 2021; 17(2):145-149.

PMID: 34421423 PMC: 8361593. DOI: 10.1177/1556331621992006.

References

Saklatvala J, Pilsworth L, Sarsfield S, Gavrilovic J, Heath J . Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J. 1984; 224(2):461-6. PMC: 1144453. DOI: 10.1042/bj2240461. View

Nouri A, Panayi G, Goodman S . Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol. 1984; 55(2):295-302. PMC: 1535803. View

Gearing A, Johnstone A, Thorpe R . Production and assay of the interleukins. J Immunol Methods. 1985; 83(1):1-27. DOI: 10.1016/0022-1759(85)90053-5. View

Kluger M, Singer R, Eiger S . Polymyxin B use does not ensure endotoxin-free solution. J Immunol Methods. 1985; 83(1):201-7. DOI: 10.1016/0022-1759(85)90073-0. View

Willoughby D, Sedgwick A, Giroud J, Al-Duaij A, De Brito F . The use of the air pouch to study experimental synovitis and cartilage breakdown. Biomed Pharmacother. 1986; 40(2):45-9. View

Dumonde D, GLYNN L . The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol. 1962; 43:373-83. PMC: 2094309. View

Rosenberg L . Chemical basis for the histological use of safranin O in the study of articular cartilage. J Bone Joint Surg Am. 1971; 53(1):69-82. View

Salmon J . A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins. 1978; 15(3):383-97. DOI: 10.1016/0090-6980(78)90122-3. View

Williams T . Prostaglandin E2, prostaglandin I2 and the vascular changes of inflammation. Br J Pharmacol. 1979; 65(3):517-24. PMC: 1668629. DOI: 10.1111/j.1476-5381.1979.tb07860.x. View

10.

Higgs G, Flower R, Vane J . A new approach to anti-inflammatory drugs. Biochem Pharmacol. 1979; 28(12):1959-61. DOI: 10.1016/0006-2952(79)90651-8. View

11.

Bernheim H, Gilbert T, Stitt J . Prostaglandin E levels in third ventricular cerebrospinal fluid of rabbits during fever and changes in body temperature. J Physiol. 1980; 301:69-78. PMC: 1279382. DOI: 10.1113/jphysiol.1980.sp013189. View

12.

Wedmore C, Williams T . Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature. 1981; 289(5799):646-50. DOI: 10.1038/289646a0. View

13.

Mizel S . Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1). Mol Immunol. 1980; 17(5):571-7. DOI: 10.1016/0161-5890(80)90155-8. View

14.

Vaes G . Cell-to-cell interactions in the secretion of enzymes of connective tissue breakdown, collagenase and proteoglycan-degrading neutral proteases. A review. Agents Actions. 1980; 10(6):474-85. DOI: 10.1007/BF02024145. View

15.

Saklatvala J . Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan in vitro. Biochem J. 1981; 199(3):705-14. PMC: 1163428. DOI: 10.1042/bj1990705. View

16.

Farndale R, Sayers C, Barrett A . A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res. 1982; 9(4):247-8. DOI: 10.3109/03008208209160269. View

17.

Duff G, Atkins E . The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods. 1982; 52(3):333-40. DOI: 10.1016/0022-1759(82)90005-9. View

18.

Salmon J, Simmons P, Palmer R . A radioimmunoassay for leukotriene B4. Prostaglandins. 1982; 24(2):225-35. DOI: 10.1016/0090-6980(82)90148-4. View

19.

Dinarello C, Marnoy S, Rosenwasser L . Role of arachidonate metabolism in the immunoregulatory function of human leukocytic pyrogen/lymphocyte-activating factor/interleukin 1. J Immunol. 1983; 130(2):890-5. View

20.

Dinarello C . An update on human interleukin-1: from molecular biology to clinical relevance. J Clin Immunol. 1985; 5(5):287-97. DOI: 10.1007/BF00918247. View